Molecular prognostic factors in penile cancer.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 18548255)

Published in World J Urol on June 12, 2008

Authors

Asif Muneer1, O Kayes, Hashim U Ahmed, Manit Arya, Suks Minhas

Author Affiliations

1: Department of Urology, University College London Hospital, 235 Euston Road, London, UK. alexmun33r@yahoo.co.uk

Articles cited by this

p53 mutations in human cancers. Science (1991) 31.96

Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer (2002) 15.46

Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med (2002) 10.80

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet (2006) 7.83

Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form. J Cell Sci (1990) 3.35

Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer (2005) 2.79

Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int J Cancer (2002) 2.39

The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity. J Pathol (2003) 2.04

Prevalence and determinants of human papillomavirus genital infection in men. Br J Cancer (2002) 1.83

Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol (2001) 1.67

Human papillomavirus-16 is the predominant type etiologically involved in penile squamous cell carcinoma. J Clin Oncol (2007) 1.53

Penile cancer. Clinical presentation, diagnosis, and staging. Urol Clin North Am (1992) 1.47

Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and in genital warts. Med Microbiol Immunol (2003) 1.45

Expression of Ki-67 in squamous cell carcinoma of the penis. BJU Int (2005) 1.39

Integration of papillomavirus DNA near myc genes in genital carcinomas and its consequences for proto-oncogene expression. J Virol (1991) 1.20

Presence of high-risk human papillomavirus DNA in penile carcinoma predicts favorable outcome in survival. Int J Cancer (2006) 1.18

Ubiquitin-independent degradation of p53 mediated by high-risk human papillomavirus protein E6. Oncogene (2007) 1.08

The prevalence of human papillomavirus genotypes in penile cancers from northern Thailand. J Med Virol (2006) 1.05

Human papillomavirus as a prognostic factor in carcinoma of the penis: analysis of 82 patients treated with amputation and bilateral lymphadenectomy. Cancer (2001) 1.05

Human papillomavirus (HPV) DNA in penile carcinomas in Argentina: analysis of primary tumors and lymph nodes. J Med Virol (2000) 1.03

Evidence for at least three alternative mechanisms targeting the p16INK4A/cyclin D/Rb pathway in penile carcinoma, one of which is mediated by high-risk human papillomavirus. J Pathol (2003) 1.01

Availability of tumor-antigen 4 as a marker of squamous cell carcinoma of the lung and other organs. Cancer (1988) 1.00

Penile verrucous carcinoma: a clinicopathologic, human papillomavirus typing and flow cytometric analysis. Mod Pathol (1992) 0.99

Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma. A clinicopathologic study. Am J Clin Pathol (1993) 0.99

Prognostic factors in carcinoma of the penis: multivariate analysis of 145 patients treated with amputation and lymphadenectomy. J Urol (1996) 0.98

Cyclooxygenase-2 and microsomal prostaglandin E synthase-1 are overexpressed in squamous cell carcinoma of the penis. Clin Cancer Res (2004) 0.92

Is the association between balanitis xerotica obliterans and penile carcinoma underestimated? BJU Int (2006) 0.91

Human papillomavirus DNA and p53 status in penile carcinomas. Int J Cancer (1998) 0.89

Squamous cell carcinoma antigen: a role in the early identification of nodal metastases in men with squamous cell carcinoma of the penis. BJU Int (2003) 0.89

Detection of the human papillomavirus and analysis of the TP53 polymorphism of exon 4 at codon 72 in penile squamous cell carcinomas. Eur J Cancer (2003) 0.89

The prognostic significance of p53, Ki-67, epithelial cadherin and matrix metalloproteinase-9 in penile squamous cell carcinoma treated with surgery. BJU Int (2007) 0.89

Nomogram predictive of pathological inguinal lymph node involvement in patients with squamous cell carcinoma of the penis. J Urol (2006) 0.88

An evaluation of squamous cell carcinoma antigen in patients with cervical squamous cell carcinoma. Am J Obstet Gynecol (1987) 0.88

Human papillomavirus-associated increase in p16INK4A expression in penile lichen sclerosus and squamous cell carcinoma. Br J Dermatol (2007) 0.88

HPV detection and p53 alteration in squamous cell verrucous malignancies of the lower genital tract. Diagn Mol Pathol (1993) 0.86

E-cadherin, MMP-2, and MMP-9 as prognostic markers in penile cancer: analysis of 125 patients. Urology (2006) 0.83

Do proliferating cell nuclear antigen and MIB-1/Ki-67 have prognostic value in penile squamous cell carcinoma? Urology (2007) 0.82

p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy. J Urol (2002) 0.82

Proliferating cell nuclear antigen counts in formalin-fixed paraffin-embedded tissue correlate with Ki-67 in fresh tissue. Am J Clin Pathol (1992) 0.82

Distinct patterns of alteration of myc genes associated with integration of human papillomavirus type 16 or type 45 DNA in two genital tumours. J Gen Virol (2000) 0.81

Prevalence of human papillomavirus types 16 and 18 in squamous-cell carcinoma of the penis: a retrospective analysis of primary and metastatic lesions by differential polymerase chain reaction. Int J Cancer (1992) 0.81

Immunoexpression of p53 protein and proliferating cell nuclear antigen in penile carcinoma. J Urol (2002) 0.81

Detection of human papillomavirus DNA, p53 and ki67 expression in penile carcinomas. Int J Immunopathol Pharmacol (2006) 0.80

Squamous cell carcinoma antigen correlates with tumor burden but lacks prognostic potential for occult lymph node metastases in penile cancer. Urology (2007) 0.79

Genetic imbalances in 26 cases of penile squamous cell carcinoma. Genes Chromosomes Cancer (2001) 0.78

Molecular pathology and clinicopathologic features of penile tumors: with special reference to analyses of p21 and p53 expression and unusual histologic features. Arch Pathol Lab Med (1999) 0.78

A c-rasHa mutation in the metastasis of a human papillomavirus (HPV)-18 positive penile squamous cell carcinoma suggests a cooperative effect between HPV-18 and c-rasHa activation in malignant progression. Cancer (1998) 0.77

Determination of telomerase activity in squamous cell carcinoma of the penis. Int J Oncol (2001) 0.77

Squamous cell carcinoma antigen (TA-4) in penile carcinoma. Urology (1990) 0.75

[Penile cancer: flow cytometry study of ploidies in 90 patients]. Prog Urol (2000) 0.75

[Verrucous carcinoma of the penis with intense basal expression of Ki 67]. Arch Esp Urol (1999) 0.75

Karyotypic findings in two cases of moderately differentiated squamous cell carcinomas of the penis. Cancer Genet Cytogenet (1999) 0.75

Clinical usage of the squamous cell carcinoma antigen in patients with penile cancer. Int J Urol (2007) 0.75

Deoxyribonucleic acid flow cytometry and traditional pathologic variables in invasive penile carcinoma: assessment of prognostic significance. Urology (1998) 0.75

Cytogenetic analysis of an invasive, poorly differentiated squamous cell carcinoma of the penis. Cancer Genet Cytogenet (1998) 0.75

Articles by these authors

Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. Eur Urol (2010) 4.45

Systematic review of complications of prostate biopsy. Eur Urol (2013) 3.66

Transperineal magnetic resonance image targeted prostate biopsy versus transperineal template prostate biopsy in the detection of clinically significant prostate cancer. J Urol (2012) 3.01

Prostate cancer screening and the management of clinically localized disease. BMJ (2013) 2.45

Long-term trends in incidence, survival and mortality of primary penile cancer in England. Cancer Causes Control (2013) 2.18

Testicular and paratesticular tumours in the prepubertal population. Lancet Oncol (2010) 2.13

Identifying candidates for active surveillance: an evaluation of the repeat biopsy strategy for men with favorable risk prostate cancer. J Urol (2012) 1.99

Is it time to consider a role for MRI before prostate biopsy? Nat Rev Clin Oncol (2009) 1.87

The index lesion and focal therapy: an analysis of the pathological characteristics of prostate cancer. BJU Int (2010) 1.74

Penile suspensory ligament division for penile augmentation: indications and results. Eur Urol (2006) 1.67

Nanotechnology: potential applications in urology. BJU Int (2006) 1.56

Analysis of the outcome of intracytoplasmic sperm injection using fresh or frozen sperm. BJU Int (2011) 1.46

Video-games station or minimally invasive skills training station? BJU Int (2009) 1.43

Benign prostatic hyperplasia: solutions to an ageing problem. Hosp Med (2002) 1.43

Multiparametric MR imaging for detection of clinically significant prostate cancer: a validation cohort study with transperineal template prostate mapping as the reference standard. Radiology (2013) 1.39

Nanotechnology and its relevance to the urologist. Eur Urol (2007) 1.38

The metastatic cascade in prostate cancer. Surg Oncol (2006) 1.30

Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy? Lancet Oncol (2012) 1.18

Scoring systems used for the interpretation and reporting of multiparametric MRI for prostate cancer detection, localization, and characterization: could standardization lead to improved utilization of imaging within the diagnostic pathway? J Magn Reson Imaging (2012) 1.18

A prospective study of 100 cases of penile cancer managed according to European Association of Urology guidelines. BJU Int (2006) 1.15

Conservative surgery for squamous cell carcinoma of the penis: resection margins and long-term oncological control. J Urol (2012) 1.10

Tumor focality in prostate cancer: implications for focal therapy. Nat Rev Clin Oncol (2010) 1.09

Part I: Primary malignant non-Wilms' renal tumours in children. Lancet Oncol (2007) 1.08

Clinical predictors of survival in men with castration-resistant prostate cancer: evidence that Gleason score 6 cancer can evolve to lethal disease. Cancer (2013) 1.08

Implants, mechanical devices, and vascular surgery for erectile dysfunction. J Sex Med (2010) 1.08

The feasibility and safety of high-intensity focused ultrasound as salvage therapy for recurrent prostate cancer following external beam radiotherapy. BJU Int (2008) 1.07

MR imaging of nonmalignant penile lesions. Radiographics (2008) 1.06

Accuracy of multiparametric magnetic resonance imaging in detecting recurrent prostate cancer after radiotherapy. BJU Int (2010) 1.06

Genital lichen sclerosus/balanitis xerotica obliterans in men with penile carcinoma: a critical analysis. BJU Int (2013) 1.05

Report of a consensus meeting on focal low dose rate brachytherapy for prostate cancer. BJU Int (2012) 1.05

Is it worth revisiting laparoscopic three-dimensional visualization? A validated assessment. Urology (2007) 1.05

Paraganglioma of the spermatic cord: case report and review of the literature. ScientificWorldJournal (2008) 1.05

The results of plaque incision and venous grafting (Lue procedure) to correct the penile deformity of Peyronie's disease. BJU Int (2005) 1.01

Primary prevention and vaccination for penile cancer. Ther Adv Urol (2013) 0.99

Multi-parametric magnetic resonance imaging to rule-in and rule-out clinically important prostate cancer in men at risk: a cohort study. Urol Int (2011) 0.98

A biopsy simulation study to assess the accuracy of several transrectal ultrasonography (TRUS)-biopsy strategies compared with template prostate mapping biopsies in patients who have undergone radical prostatectomy. BJU Int (2012) 0.97

Penile cancer: organ-sparing techniques. BJU Int (2014) 0.95

Image-directed, tissue-preserving focal therapy of prostate cancer: a feasibility study of a novel deformable magnetic resonance-ultrasound (MR-US) registration system. BJU Int (2013) 0.94

Multiparametric magnetic resonance imaging in the management and diagnosis of prostate cancer: current applications and strategies. Curr Urol Rep (2014) 0.93

Molecular and genetic pathways in penile cancer. Lancet Oncol (2007) 0.93

Microstructural characterization of normal and malignant human prostate tissue with vascular, extracellular, and restricted diffusion for cytometry in tumours magnetic resonance imaging. Invest Radiol (2015) 0.92

Current challenges in Wilms' tumor management. Nat Clin Pract Oncol (2005) 0.92

Greenlight prostatectomy: a challenge to the gold standard? A review of KTP photoselective vaporization of the prostate. Surg Laparosc Endosc Percutan Tech (2007) 0.92

The immunohistochemical profile of malignant mesotheliomas of the tunica vaginalis: a study of 20 cases. Am J Surg Pathol (2006) 0.90

Plaque incision and fascia lata grafting in the surgical management of Peyronie's disease. BJU Int (2006) 0.90

In the era of micro-dissection sperm retrieval (m-TESE) is an isolated testicular biopsy necessary in the management of men with non-obstructive azoospermia? BJU Int (2011) 0.90

Reconstructive surgery in penile trauma and cancer. Nat Clin Pract Urol (2005) 0.90

Glans resurfacing for the treatment of carcinoma in situ of the penis: surgical technique and outcomes. Eur Urol (2010) 0.89

Penile preserving surgery and surgical strategies to maximize penile form and function in penile cancer: recommendations from the United Kingdom experience. World J Urol (2008) 0.89

Photodynamic therapy for focal ablation of the prostate. World J Urol (2010) 0.88

Investigating the effects of high-dose phenylephrine in the management of prolonged ischaemic priapism. J Sex Med (2008) 0.87

Histological outcomes after focal high-intensity focused ultrasound and cryotherapy. World J Urol (2015) 0.86

Percutaneous needle biopsy for indeterminate renal masses: a national survey of UK consultant urologists. BMC Urol (2007) 0.86

Clinical trial strategy for penis cancer. BJU Int (2014) 0.86

Focal cryotherapy of localized prostate cancer: a systematic review of the literature. Expert Rev Anticancer Ther (2014) 0.85

Conservative surgery for penile cancer: subtotal glans excision without grafting. BJU Int (2005) 0.85

DNA replication licensing factors and aneuploidy are linked to tumor cell cycle state and clinical outcome in penile carcinoma. Clin Cancer Res (2009) 0.85

The management of residual curvature after penile prosthesis implantation in men with Peyronie's disease. BJU Int (2011) 0.85

Clinical applications of multiparametric MRI within the prostate cancer diagnostic pathway. Urol Oncol (2013) 0.84

The investigation of putative agents, using an in vitro model, to prevent cavernosal smooth muscle dysfunction during low-flow priapism. BJU Int (2008) 0.83

Case study: the surgical management of angiokeratoma resulting from radiotherapy for penile cancer. ScientificWorldJournal (2009) 0.83

The surgical management of lichen sclerosus of the glans penis: our experience and review of the literature. J Sex Med (2011) 0.83

The role of magnetic resonance imaging in targeting prostate cancer in patients with previous negative biopsies and elevated prostate-specific antigen levels. BJU Int (2009) 0.83

Diagnosis and management of premalignant penile lesions. Ther Adv Urol (2011) 0.83

Quantitative tissue analyses of prostate cancer foci in an unselected cystoprostatectomy series. BJU Int (2011) 0.82

Management of detrusor-external sphincter dyssynergia. Nat Clin Pract Urol (2006) 0.82

The role of magnetic resonance imaging in the local staging of penile cancer. Eur Urol (2006) 0.82

Part II: Treatment of primary malignant non-Wilms' renal tumours in children. Lancet Oncol (2007) 0.81

The role of Acucise endopyelotomy in the treatment of ureteropelvic junction obstruction. Eur Urol (2002) 0.81

A review of the efficacy of surgical treatment for and pathological changes in patients with chronic scrotal pain. BJU Int (2007) 0.81

Targeting vascular endothelial growth factor in renal cell carcinoma. Tumour Biol (2009) 0.81

Focal therapy for prostate cancer: opportunities and uncertainties. Discov Med (2011) 0.81

The Dukes staging system: a cornerstone in the clinical management of colorectal cancer. Lancet Oncol (2009) 0.81

Recurrent arteriovenous malformation of the scrotum secondary to pelvic trauma. Urol Int (2006) 0.80

Can sildenafil treat primary premature ejaculation? A prospective clinical study. Int J Urol (2007) 0.80

A nitric oxide-releasing PDE5 inhibitor relaxes human corpus cavernosum in the absence of endogenous nitric oxide. J Sex Med (2005) 0.80

Long-term follow-up after retroperitoneal laparoscopic decortication of symptomatic renal cysts. Urol Int (2007) 0.80

Expanding role of chemokines and their receptors in cancer. Expert Rev Anticancer Ther (2003) 0.80

The use of high-resolution magnetic resonance imaging in the management of patients presenting with priapism. BJU Int (2010) 0.80

The overactive bladder: review of current pharmacotherapy in adults. Part 2: treatment options in cases refractory to anticholinergics. Expert Opin Pharmacother (2006) 0.79

Anatomically versus biologically unifocal prostate cancer: a pathological evaluation in the context of focal therapy. Ther Adv Urol (2012) 0.79

Nanotechnology in the management of prostate cancer. BJU Int (2008) 0.79

Tissue microarrays and their relevance to the urologist. J Urol (2006) 0.78

Erectile dysfunction. BMJ (2014) 0.78

Biopsy strategies for selecting patients for focal therapy for prostate cancer. Curr Opin Urol (2014) 0.78

Active surveillance: is there a need for better risk stratification at the outset? J Clin Oncol (2010) 0.78

Zone-specific logistic regression models improve classification of prostate cancer on multi-parametric MRI. Eur Radiol (2015) 0.78

Tissue microarrays. Expert Rev Mol Diagn (2004) 0.77

The penile suspensory ligament: abnormalities and repair. BJU Int (2007) 0.77

Methodological considerations in assessing the utility of imaging in early prostate cancer. Curr Opin Urol (2015) 0.77

Peyronie's disease: an update of the medical management. Expert Opin Pharmacother (2004) 0.77

Testicular cancer: current update and controversies. Hosp Med (2002) 0.77

Is there a role for cardiopulmonary exercise testing before major urological surgery. BJU Int (2009) 0.77

Health technology assessment in evolution - focal therapy in localised prostate cancer. Expert Rev Anticancer Ther (2014) 0.77

Margin status after laparoscopic radical prostatectomy and the index lesion: implications for preoperative evaluation of tumor focality in prostate cancer. J Endourol (2012) 0.76